Wave Life Sciences Ltd. Ordinary Shares

WVENASDAQ • USD
ThemeGenomics & Precision Med.›RNA Therapeutics
5.73 USD
↘ 0.36 (5.91%)AT CLOSE (11:59 AM EDT)
5.68
↘ 0.06 (0.96%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
5.68
↘ 0.06 (0.96%)
🔴Market: CLOSED
Open?$6.08
High?$6.12
Low?$5.61
Prev. Close?$6.09
Volume?4.0M
Avg. Volume?4.2M
VWAP?$5.75
Rel. Volume?0.96x
Bid / Ask
Bid?$5.72 × 100
Ask?$5.92 × 100
Spread?$0.20
Midpoint?$5.82
Valuation & Ratios
Market Cap?1.1B
Shares Out?192.4M
Float?114.9M
Float %?68.7%
P/E Ratio?N/A
P/B Ratio?2.15
EPS?-$0.95
Dividend?0.00%
Ex-Dividend?N/A

Wave Life Sciences Ltd. Ordinary Shares (WVE) trades at $5.73 per share. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. WVE is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Themes
Healthcare - Genomics & Precision Medicine›RNA TherapeuticsBiotech - Drug Development›Rare Disease Therapeutics
Employees
317
Market Cap
1.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.wavelifesciences.com
Listed
2015-11-11
Address
7 STRAITS VIEW
SINGAPORE, U0 018936
Phone: 617-949-2900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
50
Short Sent.?
26
Piotroski F-Score?3/9Weak
Altman Z-Score?6.61Safe
Confidence?53%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?15.47%High
Short Interest?17.8M
Days to Cover?4.2
Free Float114.9M
Avg Daily Volume4.3M
Settlement Date2026-05-15
Financial Health
Current Ratio?11.26Strong
Quick Ratio?11.26Strong
Cash Ratio?10.93Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
71
2.15CHEAP▾
P/S?
Peers
100
S&P
3
15.36HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.9CHEAP▾
EV/Sales?
Peers
100
S&P
17
7.77HIGH▾
Returns & Efficiency
ROE?
S&P
5
-35.9%WEAK▾
ROA?
S&P
3
-31.5%WEAK▾
Cash Flow & Enterprise
FCF?$-184998000
Enterprise Value?$557.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist